VIEW MORE
Recently published in Nature Reviews Gastroenterology & Hepatology*, a comprehensive Review focused on gastric cancer and gastro-oesophageal junction cancer (GC-GOJC)...
Under the review spotlight: current insights into the molecular bases of gastric cancer, targeted treatment strategies in the pipeline, and future therapeutic opportunities
Dr. Tian Tian - Dra. Teresa Macarulla
VIEW MORE
Recently published in Clinical Cancer Research*, a journal of the American Association for Cancer Research (AACR), VHIO investigators have established...
VHIO establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery
Laboratorio de VHIO
VIEW MORE
Results of a study led by María Abad, Principal Investigator of VHIO’s Cellular Plasticity and Cancer Group, identify a new...
VHIO-led research unveils a novel microprotein as a critical regulator of epithelial cell identity with tumor suppressor activity

Latest News

Recently published in Nature Reviews Gastroenterology & Hepatology*, a comprehensive Review focused on gastric cancer and gastro-oesophageal junction cancer (GC-GOJC)...

Under the review spotlight: current insights into the molecular bases of gastric cancer, targeted treatment strategies in the pipeline, and future therapeutic opportunities
Recently published in Nature Reviews Gastroenterology & Hepatology*, a comprehensive Review focused on gastric cancer and gastro-oesophageal junction cancer (GC-GOJC)...
Dr. Tian Tian - Dra. Teresa Macarulla

Recently published in Clinical Cancer Research*, a journal of the American Association for Cancer Research (AACR), VHIO investigators have established...

VHIO establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery
Recently published in Clinical Cancer Research*, a journal of the American Association for Cancer Research (AACR), VHIO investigators have established...
Laboratorio de VHIO

Results of a study led by María Abad, Principal Investigator of VHIO’s Cellular Plasticity and Cancer Group, identify a new...

VHIO-led research unveils a novel microprotein as a critical regulator of epithelial cell identity with tumor suppressor activity
Results of a study led by María Abad, Principal Investigator of VHIO’s Cellular Plasticity and Cancer Group, identify a new...
Dr. Josep Tabernero - Dra. Enriqueta Felip

Published today, Clarivate has revealed its annual #HighlyCited2022 researchers list. Featuring among the world’s elite scientists at academic research institutes and...

Reflective of their contributions to cancer science and medicine, VHIO’s Josep Tabernero and Enriqueta Felip feature among Clarivate’s Highly Cited Researchers 2022
Published today, Clarivate has revealed its annual #HighlyCited2022 researchers list. Featuring among the world’s elite scientists at academic research institutes and...

Research Programs

PRECLINICAL & TRANSLATIONAL RESEARCH
Cellular Plasticity and Cancer Group

Our group focuses on the interplay between cellular plasticity, stem cells and cancer. Cellular plasticity is recognized today as a critical feature of cancer cells that enables them to transit between different cellular states, including reversible transitions.

Cellular Plasticity and Cancer Group
PRECLINICAL & TRANSLATIONAL RESEARCH
Growth Factors Group

We focus our research on mechanisms of resistance to targeted therapies and most importantly, how to overcome it by showing that breast cancers resistant to T-DM1, an antibody-drug conjugate ADC)- can be efficiently treated with the second generation ADC SYD985 (Nadal-Serrano et al.).

Growth Factors Group
CORE TECHNOLOGIES
Cancer Genomics Group

VHIO’s Cancer Genomics Group serves as a Core Technology laboratory. We are also dedicated to translational research as well as the development of novel genomic tests.

Cancer Genomics Group

PRINCIPAL RESEARCHERS

ENRIQUETA_FELIP
Enriqueta Felip
Thoracic Tumors & Head and Neck Cancer Group

Our group is dedicated to advancing cancer treatment and care for patients suffering from thoracic malignancies, including lung cancer, mesothelioma…

Joan_Seoane
Joan Seoane
Gene Expression and Cancer Group

We study primary brain tumors and brain metastasis; some of the most aggressive of all cancers. Both glioblastoma and brain…

Elena_Garralda
Elena Garralda
Early Clinical Drug Development Group

We focus on proof-of-concept and proof-of-mechanism trials with targeted therapies, with particular emphasis on cell signaling, cancer stem cells, and…

VILANUEVA00008
Josep Villanueva
Tumor Biomarkers Program

Our main aim is to characterize the mechanisms adopted by these cells to communicate amongst themselves as well as with…

Events

Thursday 15 December 22 - 11:00 AM Patients Maternity and cancer: how to face the disease during pregnancy, postpartum and raising of our children
Thursday 15 December 22 - 04:00 PM scientific-seminars Bruno Di Stefano | Dissecting mechanisms that govern cellular identity
Thursday 15 December 22 - 11:00 AM Patients How to learn to love yourself after cancer. Emotional management tools. Workshop 1
Thursday 15 December 22 - 04:00 PM scientific-seminars Bruno Di Stefano I Defining the Role of RNA Sequestration in Oncogenesis